Erwin R Boghaert Selected Research

Erwin R Boghaert Research Topics

21	Neoplasms (Cancer) 01/2023 - 01/2002
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 03/2004
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2004
4	Glioblastoma (Glioblastoma Multiforme) 04/2021 - 01/2016
3	Carcinoma (Carcinomatosis) 11/2020 - 01/2002
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2015 - 02/2013
2	Multiple Myeloma 01/2016 - 10/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2015 - 01/2006
1	Malignant Mesothelioma 10/2020
1	Hypoxia (Hypoxemia) 09/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2017
1	Lymphadenopathy 10/2015
1	Neutropenia 03/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2014
1	Thrombocytopenia (Thrombopenia) 10/2014
1	Lymphoma (Lymphomas) 02/2013
1	Lung Neoplasms (Lung Cancer) 06/2011
1	Paralysis (Palsy) 12/2004

11	Immunoconjugates (Immunoconjugate)IBA 04/2021 - 03/2004
7	CalicheamicinsIBA 07/2007 - 03/2004
5	venetoclaxIBA 01/2022 - 02/2013
4	AntigensIBA 04/2021 - 07/2004
4	navitoclaxIBA 01/2016 - 02/2013
4	Inotuzumab OzogamicinIBA 01/2006 - 03/2004
3	depatuxizumab mafodotinIBA 04/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2021
2	Temozolomide (Temodar)FDA LinkGeneric 04/2021 - 01/2016
2	epidermal growth factor receptor VIIIIBA 04/2021 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2004
2	depatuxizumabIBA 01/2018 - 01/2016
2	EpitopesIBA 01/2018 - 01/2016
2	Cytotoxins (Cytolysins)IBA 02/2017 - 07/2007
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2013
2	Rituximab (Mabthera)FDA Link 07/2007 - 01/2006
2	Gemtuzumab (Mylotarg)FDA Link 03/2006 - 03/2004
2	HydrazinesIBA 07/2004 - 03/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2004 - 03/2004
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	pevonedistatIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	A-1331852IBA 10/2020
1	auristatinIBA 10/2020
1	monomethyl auristatin EIBA 01/2018
1	monomethylauristatin FIBA 01/2018
1	InterleukinsIBA 09/2017
1	telisotuzumab vedotinIBA 02/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Bortezomib (Velcade)FDA Link 01/2016
1	ABT-414IBA 01/2016
1	Docetaxel (Taxotere)FDA Link 03/2015
1	A-1155463IBA 10/2014
1	AcidsIBA 07/2007
1	Immunoglobulins (Immunoglobulin)IBA 03/2006
1	hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazideIBA 07/2004
1	Lewis Y antigenIBA 07/2004
1	Ephrin-A1 (Ephrin A1)IBA 01/2002